Polycystic Liver Disease, also known as congenital polycystic disease of liver, is related to polycystic liver disease 1 with or without kidney cysts and polycystic kidney disease 3 with or without polycystic liver disease, and has symptoms including hepatosplenomegaly An important gene associated with Polycystic Liver Disease is PRKCSH (Protein Kinase C Substrate 80K-H), and among its related pathways/superpathways are WNT Signaling and MicroRNAs in cardiomyocyte hypertrophy. The drugs Lanreotide and Octreotide have been mentioned in the context of this disorder. Affiliated tissues include liver and kidney, and related phenotypes are growth/size/body region and normal